Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma

Rahal, Rami, Frick, Mareike, Romero, Rodrigo, Korn, Joshua M, Kridel, Robert, Chun Chan, Fong, Meissner, Barbara, Bhang, Hyo-eun +22 more·2014·Nature Medicine
DOI 10.1038/nm.3435

Cited by (336)

Items 301–336 of 336

  1. Molecular diagnosis of lymphoma: a case-based practical approach
    Ivonne Aidee Montes-Mojarro, Irina Bonzheim, Leticia Quintanilla‐Martínez, Falko Fend · 2019 · Diagnostic histopathology
  2. Resistance to Bruton’s Tyrosine Kinase Signaling Pathway Targeted Therapies
    Yaya Chu, Mitchell Stuart Cairo, Auke Beishuizen · 2019 · Resistance to targeted anti-cancer therapeutics
  3. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway
    Tapas Mukherjee, Yashika Ratra, Balaji Banoth, Alvina Deka, Smarajit Polley, Soumen Basak · 2021 · Methods in molecular biology
  4. Molekularbiologie maligner Lymphome
    Tabea Erdmann, Georg Lenz · 2015 · Der Onkologe
  5. Reply to Aron P. Kater et al.
    Riccardo Moia, Gianluca Gaïdano, Davide Rossi · 2020 · Haematologica
  6. Malt1-dependent cleavage of Tensin-3 controls B-cell adhesion and lymphomagenesis
    Mélanie Juilland, Nagham Alouche, Ivana Ubezzi, Montserrat Gonzalez, Tabea Erdmann, Georg Lenz, Sanjiv A. Luther, Margot Thome · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Big cells, bigger BTK resistance in mantle cell lymphoma
    Justin Taylor · 2025 · Blood
  8. Targeted therapy and outcome in chronic lymphocytic leukemia
    Sandra Eketorp Sylvan · 2014 · Figshare
  9. Molecular Genetics of Mantle Cell Lymphoma
    Alba Navarro, Sı́lvia Beà · 2014 · Encyclopedia of Life Sciences
  10. Use of Signaling Pathways as Therapeutic Targets for Blood Cancer
    Johanna Mondésir, Pierre Sujobert, Mark Alan Murakami, Marie‐Anne Hospital, Didier Bouscary, Jérôme Tamburini · 2014 · International Journal of Hematologic Oncology
  11. On Chip Analysis of CNS Lymphoma in Cerebrospinal
    Kyungheon Lee, Jun Song, Randy J. Giedt, Alexandra E. Kovach, Ephraim P. Hochberg, Hakho Lee, Ralph Weissleder · 2015
  12. Lymphoma and Lymphoproliferative Disorders
    Kathryn Rizzo · 2015 · Springer eBooks
  13. [Clinical analysis of the character and prognostic factors of 23 cases of mantle cell lymphoma].
    Rong Liang, Z Wang, Mingyu Zhu, C X Hao, N Zhang, J H Wang, T Zhang, Lan‐Yan Yang, H T Gu, B X Dong et al. · 2016 · PubMed Central
  14. Application of Modern Genome Technologies in Treatment of Lymphomas
    Marina V. Nemtsova, М В Майорова · 2016 · Clinical oncohematology
  15. BTK Inhibitors: Focus on Ibrutinib and Similar Agents
    Mattias Mattsson, Lydia Scarfò · 2018 · Resistance to targeted anti-cancer therapeutics
  16. [Clinical study and application of Ibrutinib in B-cell non-Hodgkin's lymphomas].
    S Wang, Qingsong Yin, Yanju Song · 2017 · PubMed Central
  17. Molecular and Genetic Diagnostic Approaches of Hematopoietic Disorders of the Spleen and Liver
    Jinming Song, Rohit S. Sharma, Mohammad Hussaini · 2020 · Springer eBooks
  18. Mantle Cell Lymphoma: Definition, Epidemiology, Pathobiology – Lymphomagenesis, Morphology, Variants, Immunophenotype, Prognostic Factors
    Olga V. Danilova · 2020 · Molecular and translational medicine
  19. Follicular and Mantle Cell Lymphomas: Technical and Interpretive Considerations; Karyotyping, FISH, Chromosomal Microarray, Sequencing, B Cell Clonality, Minimal Residual Disease
    Eric Y. Loo · 2020 · Molecular and translational medicine
  20. Inhibition of Cyclin Dependent Kinase 9 Synergistically Enhanced Venetoclax Activity in Mantle Cell Lymphoma Cells
    Xiaoxian Zhao, Juraj Bodo, Ruoying Chen, Lisa M. Durkin, Andrew James Souers, Darren C. Phillips, Eric D. Hsi · 2016 · Blood
  21. Development of Small Molecule Kinase Degraders as Chemical Biology Probes and Cancer Therapies
    Dennis Dobrovolsky · 2018 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  22. Lymphomas
    Vignesh Shanmugam, Annette S. Kim · 2019 · Springer eBooks
  23. Mantle Cell Lymphoma
    2016 · Elsevier eBooks
  24. Dismantling the Status Quo: Venetoclax in Mantle Cell Lymphoma
    Joshua M. L. Casan, Mary Ann Anderson, John Francis Seymour · 2022 · Medical Research Archives
  25. Mantle cell lymphoma: what clinical progress in the last 5 years?
    Charbel Soueidy, Jean‐Marie Michot, Vincent Ribrag · 2025 · Expert Opinion on Investigational Drugs
  26. Lymphomas: molecular subsets and advances in therapeutics
    Sandeep Dave · 2022 · Elsevier eBooks
  27. Étude des anomalies de XPO1 dans les lymphomes B
    Hadjer Miloudi · 2020 · theses.fr (ABES)
  28. Marqueurs moléculaires d’intérêt pronostique et thérapeutique chez les patients atteints de lymphome à cellules du manteau
    Yannick Le Bris · 2020
  29. Analyse pharmacocinétique-pharmacodynamique de l'ibrutinib dans le contexte d'une étude multidisciplinaire pour le traitement de la leucémie lymphoïde chronique
    Fanny Gallais · 2020
  30. Elucidating the Vulnerability of Glioblastoma Stem-like Cells to Lysosomal Dysfunctions
    Clément Maghe · 2023 · theses.fr (ABES)
  31. Cyclin-Dependent Kinase-9 and Oxidative Phosphorylation Inhibition Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma
    Carly Roleder, Xiaofan Zhao, Vi Lam, Haifeng Shen, Edward C. Dominguez, Canping Chen, Sonia Rodrı́guez, L Y Wang, Tycel Phillips, Zheng Xia et al. · 2026 · Cancer Research Communications
  32. Molecular Insights and Novel Therapies for Lymphoproliferative Disorders
    Shucen Wan, Seema G Naik · 2026 · International Journal of Molecular Sciences
  33. Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases
    Miao Sun, Dengju LI, Jia Wei · 2026 · MedComm
  34. BindingDB Entry 50017406: An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase.
    BindingDB · 2023 · UC San Diego
  35. A functional R/Seurat pipeline implementing the NF-κB / GR / p53 single-cell resistance-axis framework, operationalizing the model of 'Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment'
    Spiros Vlahopoulos · 2026 · Zenodo (CERN European Organization for Nuclear Research)
  36. BindingDB Entry 50016410: Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.
    BindingDB · 2023 · UC San Diego